Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators..

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360.

2.

Engaging U.S. veterans with PTSD in online therapy.

Parish MB, Apperson M, Yellowlees PM.

Psychiatr Serv. 2014 May 1;65(5):697. doi: 10.1176/appi.ps.650501. No abstract available.

PMID:
24788736
3.

Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.

Apperson ML, Tian Y, Stamova B, Ander BP, Jickling GC, Agius MA, Sharp FR.

J Neuroimmunol. 2013 Apr 15;257(1-2):90-6. doi: 10.1016/j.jneuroim.2013.02.004.

PMID:
23477965
4.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators..

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

5.

Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis.

Magley J, Towner D, Taché V, Apperson ML.

Obstet Gynecol. 2012 Aug;120(2 Pt 2):480-3. doi: 10.1097/AOG.0b013e31825935d4.

PMID:
22825272
6.

Treatment of γ-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroids.

Goldenholz DM, Wong VS, Bateman LM, Apperson M, Oskarsson B, Akhtar S, Wheelock V.

Arch Neurol. 2012 Aug;69(8):1061-3. doi: 10.1001/archneurol.2012.197.

PMID:
22507884
7.

Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study.

Dias RA, Hardin KA, Rose H, Agius MA, Apperson ML, Brass SD.

Sleep Breath. 2012 Dec;16(4):1255-65. doi: 10.1007/s11325-011-0642-6.

PMID:
22270686
8.

Clinical and neuroimaging assessments for research studies (including drug trials) in multiple sclerosis.

Apperson ML, Agius MA.

Curr Protoc Neurosci. 2011 Jan;Chapter 10:Unit10.4. doi: 10.1002/0471142301.ns1004s54.

PMID:
21207365
9.

Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.

Tian Y, Apperson ML, Ander BP, Liu D, Stomova BS, Jickling GC, Enriquez R, Agius MA, Sharp FR.

J Neuroimmunol. 2011 Jan;230(1-2):124-9. doi: 10.1016/j.jneuroim.2010.09.001.

PMID:
20920832
10.

Brief alcohol intervention for college drinkers: how brief is?

Kulesza M, Apperson M, Larimer ME, Copeland AL.

Addict Behav. 2010 Jul;35(7):730-3. doi: 10.1016/j.addbeh.2010.03.011.

PMID:
20381972
11.

Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood.

Stamova BS, Apperson M, Walker WL, Tian Y, Xu H, Adamczy P, Zhan X, Liu DZ, Ander BP, Liao IH, Gregg JP, Turner RJ, Jickling G, Lit L, Sharp FR.

BMC Med Genomics. 2009 Aug 5;2:49. doi: 10.1186/1755-8794-2-49.

12.

FMR1 premutation in females diagnosed with multiple sclerosis.

Zhang L, Coffey S, Lua LL, Greco CM, Schafer JA, Brunberg J, Borodyanskaya M, Agius MA, Apperson M, Leehey M, Tartaglia N, Tassone F, Hagerman PJ, Hagerman RJ.

J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):812-4. doi: 10.1136/jnnp.2008.160960. No abstract available.

PMID:
19531693
13.

Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy.

Lit L, Sharp FR, Apperson M, Liu DZ, Walker WL, Liao I, Xu H, Ander BP, Wong B.

Pharmacogenomics J. 2009 Dec;9(6):411-8. doi: 10.1038/tpj.2009.22.

PMID:
19488064
14.

The relative impact of nicotine dependence, other substance dependence, and gender on Bechara Gambling Task performance.

Businelle MS, Apperson MR, Kendzor DE, Terlecki MA, Copeland AL.

Exp Clin Psychopharmacol. 2008 Dec;16(6):513-20. doi: 10.1037/a0013510.

PMID:
19086772
15.

Gene expression in blood of subjects with Duchenne muscular dystrophy.

Wong B, Gilbert DL, Walker WL, Liao IH, Lit L, Stamova B, Jickling G, Apperson M, Sharp FR.

Neurogenetics. 2009 Apr;10(2):117-25. doi: 10.1007/s10048-008-0167-8.

PMID:
19067001
16.

Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke.

Xu H, Tang Y, Liu DZ, Ran R, Ander BP, Apperson M, Liu XS, Khoury JC, Gregg JP, Pancioli A, Jauch EC, Wagner KR, Verro P, Broderick JP, Sharp FR.

J Cereb Blood Flow Metab. 2008 Jul;28(7):1320-8. doi: 10.1038/jcbfm.2008.22.

17.

Genomic profiles of stroke in blood.

Sharp FR, Xu H, Lit L, Walker W, Pinter J, Apperson M, Verro P.

Stroke. 2007 Feb;38(2 Suppl):691-3. Review.

18.

The future of genomic profiling of neurological diseases using blood.

Sharp FR, Xu H, Lit L, Walker W, Apperson M, Gilbert DL, Glauser TA, Wong B, Hershey A, Liu DZ, Pinter J, Zhan X, Liu X, Ran R.

Arch Neurol. 2006 Nov;63(11):1529-36. Review.

PMID:
17101821
19.

Genomics of brain and blood: progress and pitfalls.

Sharp FR, Lit L, Xu H, Apperson M, Walker W, Wong B, Gilbert DL, Hershey A, Glauser TA.

Epilepsia. 2006 Oct;47(10):1603-7. Review.

20.

Psychogenic nonepileptic seizures are associated with an increased risk of obesity.

Marquez AV, Farias ST, Apperson M, Koopmans S, Jorgensen J, Shatzel A, Alsaadi TM.

Epilepsy Behav. 2004 Feb;5(1):88-93.

PMID:
14751212
Items per page

Supplemental Content

Loading ...
Support Center